A Hemodynamic Study to assess response, tolerance and dose optimization of Carvedilol in Child Class A patients with Portal Hypertension
Background: Carvedilol has an established role in Chronic Liver disease (CLD) associated Portal Hypertension, however its role in specific subclasses of CLD has not been studied, neither the factors leading to non-response thereby predisposing such patients to variceal bleed with empiric therapy....
Main Authors: | Shaheen Nazir, Zeeshan Ahmed, Muzzafer Mohamad, Afaq Ahmad, Wasim Ahmed, Inaam -ul- Haq, Altaf Hussain |
---|---|
Format: | Article |
Language: | English |
Published: |
Manipal College of Medical Sciences, Pokhara
2021-08-01
|
Series: | Asian Journal of Medical Sciences |
Subjects: | |
Online Access: | https://www.nepjol.info/index.php/AJMS/article/view/36500 |
Similar Items
-
Carvedilol in the treatment of portal hypertension
by: Hamdan Al-Ghamdi
Published: (2011-01-01) -
A comparative analysis of carvedilol and propranolol in hepatic venous pressure gradient reduction in patients with cirrhotic portal hypertension
by: LI Jing, et al.
Published: (2016-01-01) -
Research advances in role of carvedilol in management of cirrhotic portal hypertension: a review of clinical trials
by: YANG Chunjiao
Published: (2015-03-01) -
BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL
by: I. T. Murkamilov, et al.
Published: (2017-07-01) -
Carvedilol-Induced Liver Injury, a Rare Cause of Mixed Hepatitis: A Clinical Case
by: João Rua, et al.
Published: (2018-07-01)